Poolbeg Pharma signs Artificial Intelligence deal with CytoReason to identify drug targets for influenza
Poolbeg Pharma (AIM: POLB, ‘Poolbeg’ or the ‘Company’), a clinical stage infectious disease pharmaceutical company with a unique capital light clinical…